Olprinone
Alternative Names: Coretec; E 1020; LoprinoneLatest Information Update: 04 Aug 2005
At a glance
- Originator Eisai Co Ltd
- Class Bronchodilators; Cardiotonics; Imidazoles; Pyridones; Small molecules
- Mechanism of Action Type 3 cyclic nucleotide phosphodiesterase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Marketed Heart failure
- Discontinued Acute asthma; Asthma; Reperfusion injury
Most Recent Events
- 04 Aug 2005 Discontinued - Clinical-Phase-Unknown for Acute asthma in Japan (IV-infusion)
- 04 Aug 2005 Discontinued - Clinical-Phase-Unknown for Asthma in Japan (Inhalation)
- 04 Aug 2005 Discontinued - Clinical-Phase-Unknown for Reperfusion injury in Japan (IV-infusion)